Targeting angiogenesis with compounds from the extracellular matrix
D Belotti, C Foglieni, A Resovi, R Giavazzi… - The international journal …, 2011 - Elsevier
The extracellular matrix (ECM) is the central element of a pericellular network of bioactive
molecules. It orchestrates molecular interactions, availability and activity, acting as a key …
molecules. It orchestrates molecular interactions, availability and activity, acting as a key …
[HTML][HTML] Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment
D Bourboulia, S Jensen-Taubman, MR Rittler… - The American journal of …, 2011 - Elsevier
Tissue inhibitor of matrix metalloproteinase–2 (TIMP-2) belongs to a small family of
endogenous proteins that inhibits a group of enzymes, the matrix metalloproteinases …
endogenous proteins that inhibits a group of enzymes, the matrix metalloproteinases …
Anti-tumoral properties of endogenous angiogenesis inhibitors: A case for continued TIMP-2 preclinical development
W G. Stetler-Stevenson, D Bourboulia… - Current …, 2012 - benthamdirect.com
Dr. Judah Folkman first introduced the concept of anti-angiogenic therapy almost four
decades ago. This novel idea has subsequently been supported by extensive research in …
decades ago. This novel idea has subsequently been supported by extensive research in …